Rigorous tissue and biomarker analyses to accelerate the testing and approval of therapies for genetic disease
Our specialty lies in rigorous and quantitative assessments of tissue biomarkers and histopathology to bolster the development of treatments for genetic diseases.
Our top areas of expertise include:
• Neuromuscular, cardiovascular, and neurodegenerative diseases
• Safety and toxicity
• Assistance in planning and coordinating biopsy studies
• Regulatory compliance and reporting
